Home Articles List Article Information
Alexandria Dental Journal
Journal Archive
Volume Volume 49 (2024)
Volume Volume 48 (2023)
Volume Volume 47 (2022)
Volume Volume 46 (2021)
Volume Volume 45 (2020)
Volume Volume 44 (2019)
Volume Volume 43 (2018)
Volume Volume 42 (2017)
Volume Volume 41 (2016)
Volume Volume 40 (2015)
Tolba, Y., Omar, S., Nagy, D. (2019). A BIOCHEMICAL STUDY OF THE EFFECT OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN MANAGEMENT OF TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS IN RATS. Alexandria Dental Journal, 44(3), 89-92. doi: 10.21608/adjalexu.2019.63564
Yasmine M. Tolba; Samia S. Omar; Dina A. Nagy. "A BIOCHEMICAL STUDY OF THE EFFECT OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN MANAGEMENT OF TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS IN RATS". Alexandria Dental Journal, 44, 3, 2019, 89-92. doi: 10.21608/adjalexu.2019.63564
Tolba, Y., Omar, S., Nagy, D. (2019). 'A BIOCHEMICAL STUDY OF THE EFFECT OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN MANAGEMENT OF TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS IN RATS', Alexandria Dental Journal, 44(3), pp. 89-92. doi: 10.21608/adjalexu.2019.63564
Tolba, Y., Omar, S., Nagy, D. A BIOCHEMICAL STUDY OF THE EFFECT OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN MANAGEMENT OF TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS IN RATS. Alexandria Dental Journal, 2019; 44(3): 89-92. doi: 10.21608/adjalexu.2019.63564

A BIOCHEMICAL STUDY OF THE EFFECT OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN MANAGEMENT OF TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS IN RATS

Article 17, Volume 44, Issue 3, December 2019, Page 89-92  XML PDF (217.74 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2019.63564
View on SCiNiTO View on SCiNiTO
Authors
Yasmine M. Tolba email orcid 1; Samia S. Omar2; Dina A. Nagy3
1Demonstrator of Oral Biology, Faculty of Dentistry, Alexandria University.
2Professor of Oral Biology, Faculty of Dentistry, Alexandria University.
3Lecturer of Oral Biology, Faculty of Dentistry, Alexandria University.
Abstract
INTRODUCTION: Osteoarthritis is one of the most common degenerative diseases affecting the joints. Adjuvant- induced arthritis (AIA) is an experimental model of polyarthritis which has been widely used for preclinical testing of several anti-arthritic agents and investigating the pathogenesis of arthritis. A modified model of AIA was used in this study, where the disease was induced in one joint. Hyaluronic acid deals with the degenerative effects of arthritis from 3 different aspects: mechanically by maintaining lubrication, metabolically by providing nutritional materials to the articular disc and biologically by decreasing inflammatory effects. OBJECTIVES: to study the biochemical actions of high molecular weight hyaluronic acid (HMWHA) in management of temporomandibular joint (TMJ) adjuvant induced arthritis by detecting matrix metalloproteinase-3 (MMP3) concentration in TMJ tissue extract. MATERIALS AND METHODS: 14 male albino rats were divided into 2 equal groups and in each group a split mouth design was used. •Study I: Arthritis was induced in 7 animals through a single intra-articular injection of Complete Freund's Adjuvant (CFA) in the left TMJs. (50µl) •Study II: Arthritis was induced in the other 7 animals through a single intra-articular injection of CFA and treated with an intra-articular injection of HMWHA into their left TMJs, once a week for total of three injections. 7 animals were sacrificed on day 7 of the disease while the other 7 animals were sacrificed one week after the last injection of HMWHA. Elisa test was performed to detect MMP 3 which is considered as a biomarker of the disease progression RESULTS: The concentration of MMP-3 of study I (diseased group) on day 7 was found to be significantly higher than that of study II (treated group) on day 28. CONCLUSIONS: High molecular weight hyaluronic acid is capable of management of osteoarthritic TMJs.
Keywords
TMJ; Arthritis; High molecular weight hyaluronic acid; MMP-3
Main Subjects
Oral biology
References
  1. Hashizume M, Koike N, Yoshida H. High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis. Mod Rheumatol. 2010;20:432–8.
  2. Kalladka M, Quek S, Heir G, Eliav E, Mupparapu M, Viswanath A. Temporomandibular joint osteoarthritis: Diagnosis and long-term Conservative management: A topic review. J Indian Prosthodont Soc. 2014;14:6–15.
  3. Tanaka E, Detamore MS, Mercuri LG. Degenerative Disorders of the Temporomandibular Joint: Etiology, Diagnosis, and Treatment. J Dent Res. 2008;87:296–307.
  4. Bansal M. Prevalence and diagnostic features of osteoarthrosis of the temporomandibular joint: a review. Int J Res Orthop. 2016;2:1–4.
  5. Iturriaga V, Vásquez B, Manterola C, del Sol M. Role of Hyaluronic Acid in the Homeostasis and Therapeutics of Temporomandibular Joint Osteoarthritis. Int J Morphol. 2017;35:870–6.
  6. Tanne K, Okamoto Y, Su S-C, Mitsuyoshi T, AsakawaTanne Y, Tanimoto K. Current status of temporomandibular joint disorders and the therapeutic system derived from a series of biomechanical, histological, and biochemical studies. APOS Trends Orthod. 2015;5:4–21.
  7. Jabłońska-trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31:177–83.
  8. Chen J, Huang J, Du W, Tong P. Expression and significance of MMP3 in synovium of knee joint at different stage in osteoarthritis patients. Asian Pac J Trop Med. 2014;7:297–300.
  9. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11(July 2016):529–43.
  10. Kogan G, Šoltés L, Stern R, Gemeiner P. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett. 2007;29:17–25.
  11. Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid (hyaluronan): A review. Vet Med (Praha). 2008;53:397– 411.
  12. Harper RP, Kerins CA, McIntosh JE, Spears R, Bellinger LL. Modulation of the inflammatory response in the rat TMJ with increasing doses of complete Freund’s adjuvant. Osteoarthr Cartil. 2001;9:619–24.
  13. Kuroki Y, Honda K, Kijima N, Wada T, Arai Y, Matsumoto N, et al. In vivo morphometric analysis of inflammatory condylar changes in rat temporomandibular joint. Oral Dis. 2011;17:499–507.
  14. Lemos GA, Rissi R, de Souza Pires IL, de Oliveira LP, de Aro AA, Pimentel ER, et al. Low-level laser therapy stimulates tissue repair and reduces the extracellular matrix degradation in rats with induced arthritis in the temporomandibular joint. Lasers Med Sci. 2016;31:1051–9.
  15. G.Duygu, N.Güler, B.Çam, M.Kürkçü. The effects of high molecular weight hyaluronic acid ( Hylan G-F 20 ) on experimentally induced temporomandibular joint osteoartrosis : part II. Int J Oral Maxillofac Surg. 2011;40:1406–13.
  16. Lemos GA, Rissi R, Pimentel ER, Palomari ET. Effects of high molecular weight hyaluronic acid on induced arthritis of the temporomandibular joint in rats. Acta Histochem. 2015;117:566–75.
  17. Considerations A, Specific S, Formulary V, Introduction I. Veterinary Anesthetic and Analgesic Formulary. 2012;1–22.
  18. Yang C, Lin C, Wang H, Lyu S. Matrix Metalloproteases and Tissue Inhibitors of Metalloproteinases in Medial Plica and Pannus-like Tissue Contribute to Knee Osteoarthritis Progression. PLoS One. 2013;8:1–11.
  19. Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res. 2016;1–27.
  20. Corrado A, Neve A, Cantatore FP. Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clin Exp Med. 2013;13:81–4.
  21. Butler SH, Godefroy F, Besson JM, Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain. 1992;48:73–81.
  22. Donaldson LF, Seckl JR, McQueen DS. A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose. J Neurosci Methods. 1993;49:5–10.
  23. Campo GM, Avenoso A, Nastasi G, Micali A, Prestipino V, Vaccaro M, et al. Hyaluronan reduces in fl ammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta. 2011;1812:1170–81.
  24. Machado E, Bonotto D, Cunali PA. Intra-articular injections with corticosteroids and sodium hyaluronate for treating temporomandibular joint disorders: a systematic review. Dental Press J Orthod. 2013;18:128–33.
  25. Triantaffilidou K, Venetis G, Bika O. Efficacy of hyaluronic acid injections in patients with osteoarthritis of the temporomandibular joint. A comparative study. J Craniofac Surg. 2013;24:2006–9.
  26. Jørgensen A, Stengaard-pedersen K, Simonsen O, Eriksen C, Bliddal H, Pedersen NW, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. 2010;69:1097- 102.
Statistics
Article View: 340
PDF Download: 745